Halis Akalın
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antifungal resistance and susceptibility 32
- HIV/AIDS Research and Interventions 8
-
- Antibiotic Resistance in Bacteria 37
- Co-authors
- Deniz Gür (12 shared papers)Murat Akova (12 shared papers)Beyza Ener (36 shared papers)Suna Gedikoğlu (9 shared papers)Haluk Barbaros Oral (19 shared papers)S Helvaci (8 shared papers)Serhat Ünal (11 shared papers)Ömrüm Uzun (7 shared papers)
- Journals
- Journal of Chemotherapy (7 papers)European Journal of Clinical Microbiology & Infectious Diseases (7 papers)International Journal of Antimicrobial Agents (6 papers)Mycoses (5 papers)Scandinavian Journal of Infectious Diseases (5 papers)
- Partner nations
- TürkiyeUnited StatesGermany
In The Last Decade
Halis Akalın
173 papers receiving 4.2k citations
Halis Akalın's Hit Papers
Peers
Comparison fields: 5 of 116
- Molecular Medicine 773
- Infectious Diseases 1.7k
- Applied Microbiology and Biotechnology 136
- Small Animals 249
- Critical Care and Intensive Care Medicine 117
Countries citing papers authored by Halis Akalın
This map shows the geographic impact of Halis Akalın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halis Akalın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halis Akalın more than expected).
Fields of papers citing papers by Halis Akalın
This network shows the impact of papers produced by Halis Akalın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halis Akalın. The network helps show where Halis Akalın may publish in the future.
Co-authors
The 25 scholars most cited alongside Halis Akalın, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey Hit paper breakdown → | 2021 | 716 |
| 2 | 1993 | 152 | |
| 3 | 2000 | 126 | |
| 4 | Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study Hit paper breakdown → | 2023 | 106 |
| 5 | 2018 | 104 | |
| 6 | 1993 | 92 | |
| 7 | 2006 | 92 | |
| 8 | 2006 | 92 | |
| 9 | 2010 | 86 | |
| 10 | 2009 | 84 | |
| 11 | 1991 | 83 | |
| 12 | 2006 | 79 | |
| 13 | 2021 | 72 | |
| 14 | 1999 | 71 | |
| 15 | 1995 | 70 | |
| 16 | 1992 | 66 | |
| 17 | 2001 | 66 | |
| 18 | Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study Hit paper breakdown → | 2024 | 65 |
| 19 | 2016 | 60 | |
| 20 | 1983 | 56 |
About Halis Akalın
Halis Akalın is a scholar working on Infectious Diseases, Molecular Medicine, Small Animals, Epidemiology and Critical Care and Intensive Care Medicine, having authored 190 papers that have together received 4.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (37 papers), Antifungal resistance and susceptibility (32 papers), Brucella: diagnosis, epidemiology, treatment (13 papers), Sepsis Diagnosis and Treatment (9 papers), Nosocomial Infections in ICU (9 papers), HIV/AIDS Research and Interventions (8 papers), Pneumonia and Respiratory Infections (7 papers) and Antibiotic Use and Resistance (7 papers). The work is most often cited by research in Molecular Medicine (773 citations), Infectious Diseases (1.7k citations), Applied Microbiology and Biotechnology (136 citations), Small Animals (249 citations) and Critical Care and Intensive Care Medicine (117 citations). Halis Akalın has collaborated with scholars based in Türkiye, United States and Germany. Frequent co-authors include Deniz Gür, Murat Akova, Beyza Ener, Suna Gedikoğlu, Haluk Barbaros Oral, S Helvaci, Serhat Ünal, Ömrüm Uzun, David M. Livermore and Cüneyt Özakın. Their work appears in journals such as Journal of Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases, International Journal of Antimicrobial Agents, Mycoses and Scandinavian Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.